Teva Pharma Industries Ltd ADR

Stock Chart, Company Information, and Scan Results

$18.80(as of Aug 21, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Teva Pharma Industries Ltd ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$18.80
Ticker SymbolTEVA
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees37,000
CountyUSA
Market Cap$20,225.6M
EBIDTA4,522.0M
10-Day Moving Average17.40
P/E Ratio-138.14
20-Day Moving Average16.75
Forward P/E Ratio6.78
50-Day Moving Average16.73
Earnings per Share-0.15
200-Day Moving Average17.20
Profit Margin6.75%
RSI71.66
Shares Outstanding1,147.1M
ATR0.53
52-Week High22.80
Volume20,138,544
52-Week Low12.47
Most Recent Support Level17.33
Book Value18,695.0M
Most Recent Resistance Level18.28
P/B Ratio1.17
Upper Keltner17.94
P/S Ratio1.31
Lower Keltner15.55
Debt-to-Equity Ratio17.94
Next Earnings Date11/06/2025
Cash Surplus-9,700.0M
Next Ex-Dividend DateUnknown

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders " chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Teva Pharma Industries Ltd ADR In Our Stock Scanner

As of Aug 22, 2025
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Morning StarScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.